Meta-analysis of 6 placebo-controlled RCTs (18,011 pregnant women; 17,769 infants): maternal RSV vaccination reduced severe infant RSV lower respiratory tract infection (RR 0.35) and hospitalisation (RR 0.53) within 180 days; no safety signal for preterm birth (RR 1.15).
Meta-analysisn = 18,011 pregnant women
Lopes et al. The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials